Clinical trials
Completed trials in Germany
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18,011 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 66 |
| 2001 | 156 |
| 2002 | 216 |
| 2003 | 345 |
| 2004 | 463 |
| 2005 | 529 |
| 2006 | 689 |
| 2007 | 768 |
| 2008 | 864 |
| 2009 | 959 |
| 2010 | 1,017 |
| 2011 | 1,118 |
| 2012 | 1,042 |
| 2013 | 931 |
| 2014 | 1,006 |
| 2015 | 1,024 |
| 2016 | 977 |
| 2017 | 992 |
| 2018 | 917 |
| 2019 | 843 |
| 2020 | 761 |
| 2021 | 695 |
| 2022 | 519 |
| 2023 | 439 |
| 2024 | 313 |
| 2025 | 114 |
| 2026 | 23 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18,011 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 701 |
| Boehringer Ingelheim | 628 |
| GlaxoSmithKline | 532 |
| Bayer | 464 |
| Charite University, Berlin, Germany | 448 |
| Hoffmann-La Roche | 424 |
| AstraZeneca | 397 |
| Novo Nordisk A/S | 360 |
| Pfizer | 310 |
| Eli Lilly and Company | 308 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 604 |
| Diabetes Mellitus | 421 |
| Pulmonary Disease, Chronic Obstructive | 418 |
| Breast Neoplasms | 361 |
| Asthma | 303 |
| Heart Failure | 299 |
| Neoplasms | 299 |
| Arthritis, Rheumatoid | 258 |
| Carcinoma, Non-Small-Cell Lung | 255 |
| Atrial Fibrillation | 248 |
Trials
Showing 1 to 25 of 18,011. Each trial links to its page on Pharma Observatory.
17,911 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.